Baillie Gifford & Co
AGIO icon

Baillie Gifford & Co’s Agios Pharmaceuticals AGIO Stock Holding History

Baillie Gifford & Co’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-186
Closed -$4.27K – 301
2023
Q1 		$4.27K Hold
186
– – ﹤0.01% 425
2022
Q4 		$5.22K Hold
186
– – ﹤0.01% 445
2022
Q3 		$5K Hold
186
– – ﹤0.01% 442
2022
Q2 		$4K Hold
186
– – ﹤0.01% 458
2022
Q1 		$5K Hold
186
– – ﹤0.01% 463
2021
Q4 		$6K Hold
186
– – ﹤0.01% 471
2021
Q3 		$9K Hold
186
– – ﹤0.01% 453
2021
Q2 		$10K Hold
186
– – ﹤0.01% 432
2021
Q1 		$10K Buy
186
+3
+2% +$149 ﹤0.01% 401
2020
Q4 		$8K Buy
+183
New +$7.24K ﹤0.01% 393
2020
Q1 		– Sell
-1,709
Closed -$82K – 226
2019
Q4 		$82K Sell
1,709
-1,081,985
-100% -$40.9M ﹤0.01% 221
2019
Q3 		$35.1M Buy
1,083,694
+3,865
+0.4% +$160K 0.04% 137
2019
Q2 		$53.9M Buy
1,079,829
+207,604
+24% +$11.1M 0.06% 121
2019
Q1 		$58.8M Buy
872,225
+9,510
+1% +$554K 0.06% 117
2018
Q4 		$39.8M Buy
862,715
+192,272
+29% +$11.9M 0.05% 123
2018
Q3 		$51.7M Buy
670,443
+43,840
+7% +$3.53M 0.06% 119
2018
Q2 		$52.8M Buy
626,603
+44,462
+8% +$3.88M 0.06% 111
2018
Q1 		$47.6M Buy
+582,141
New +$45M 0.06% 108

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baillie Gifford & Co's AGIO Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Agios Pharmaceuticals (AGIO) in Q2 2023, closing a stake of 186 shares — an estimated $4.27K sold.

Baillie Gifford & Co first reported a position in AGIO in Q1 2018 and held it in 18 quarters. The position peaked at $58.8M in Q1 2019. 153 funds tracked by Wall St. Rank hold AGIO as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Agios Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 186 Agios Pharmaceuticals shares in Q2 2023, an estimated $4.27K.
  • Baillie Gifford & Co first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 18 quarters.
  • Baillie Gifford & Co's Agios Pharmaceuticals position peaked at $58.8M in Q1 2019.
  • 153 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.